Skip to main content

Aussie Hospital Buys Partek's Genomics Suite Software to Study Cancer, Metabolic Disorders

NEW YORK (GenomeWeb News) — The Women’s & Children’s Hospital in Adelaide, Australia, has bought Partek’s data-handling software, Partek said today.  
Partek said the Department of Genetic Medicine at the Women’s and Children’s Hospital will use the Partek Genomics Suite software to analyze data in studies of cancer, birth defects, and metabolic disorders.
Missouri-based Partek is a genomics software developer specializing in an Affymetrix GeneChip-compatible platform that is used to identify and quantify data patterns.
Partek said the software handles data from “genomic and proteomic studies, high throughput screening campaigns and computer aided drug design.”
Financial terms of the sale were not released.

Filed under

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.